Cargando…

Evaluation of the Role of BIOCHIP Mosaic Based Indirect Immunofluorescence and ELISA BP 180 and BP 230 Autoantibodies in the Diagnosis of Bullous Pemphigoid Patients

BACKGROUND: Bullous pemphigoid (BP) is characterized by tissue-bound and circulating Immunoglobulin G (IgG) autoantibodies against BP 180 and BP 230. Diagnosis of BP is a multi-step procedure. Enzyme-linked immunosorbent assay (ELISA) is a quantitative analysis of target antigens, whereas BIOCHIP mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nithya, VPS, Rai, Reena, Boppe, Appalaraju, Chaithra, V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650752/ https://www.ncbi.nlm.nih.gov/pubmed/36386758 http://dx.doi.org/10.4103/idoj.idoj_68_22

Ejemplares similares

Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid
por: Nagarajan, Harish, et al.
Publicado: (2023)

Deciphering the Contribution of BP230 Autoantibodies in Bullous Pemphigoid
por: Cole, Connor, et al.
Publicado: (2022)

Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: A pilot study
por: Sernicola, Alvise, et al.
Publicado: (2019)

Analysis of the autoimmune response against BP180 and BP230 in ethnic Poles with neurodegenerative disorders and bullous pemphigoid
por: Gornowicz-Porowska, Justyna, et al.
Publicado: (2017)

BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid
por: Liu, Yale, et al.
Publicado: (2017)

Diagnostic values of indirect immunofluorescence using salt-split skin, direct immunofluorescence and BP180 NC16A ELISA on bullous pemphigoid
por: Li, Suo, et al.
Publicado: (2022)

A Cross-Sectional Study to Correlate Disease Severity in Bullous Pemphigoid Patients with Serum Levels of Autoantibodies Against BP180 and BP230
por: Muhammed, Naziya, et al.
Publicado: (2021)

Usefulness of Enzyme-linked Immunosorbent Assay Using Recombinant BP180 and BP230 for Serodiagnosis and Monitoring Disease Activity of Bullous Pemphigoid
por: Lee, Eui Hyung, et al.
Publicado: (2012)

Association of Autoantibodies to BP180 with Disease Activity in Greek Patients with Bullous Pemphigoid
por: Patsatsi, Aikaterini, et al.
Publicado: (2012)

Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody
por: Clapé, Ariane, et al.
Publicado: (2018)

Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases
por: Csorba, Kinga, et al.
Publicado: (2011)

Comparative Analysis of BIOCHIP Mosaic-Based Indirect Immunofluorescence with Direct Immunofluorescence in Diagnosis of Autoimmune Bullous Diseases: A Cross-Sectional Study
por: Arunprasath, P., et al.
Publicado: (2020)

Comparative Analysis of BIOCHIP Mosaic-based Indirect Immunofluorescence with Direct Immunofluorescence in Diagnosis of Autoimmune Bullous Diseases: A Cross-Sectional Study
por: Arunprasath, P, et al.
Publicado: (2021)

Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180
por: Mai, Yosuke, et al.
Publicado: (2019)

Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180): identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and alpha 6 integrin
Publicado: (1995)

Biochip Technology for the Serological Diagnosis of Bullous Pemphigoid
por: Zarian, Haik, et al.
Publicado: (2012)

Pilot study investigating BP-180 in extracellular vesicles derived from blister fluid of bullous pemphigoid patients
por: Gasparini, Giulia, et al.
Publicado: (2023)

The Localization of Bullous Pemphigoid Antigen 180 (BP180) in Hemidesmosomes Is Mediated by Its Cytoplasmic Domain and Seems to be Regulated by the β4 Integrin Subunit
por: Borradori, Luca, et al.
Publicado: (1997)

High Index Values of Enzyme-Linked Immunosorbent Assay for BP180 at Baseline Predict Relapse in Patients With Bullous Pemphigoid
por: Koga, Hiroshi, et al.
Publicado: (2018)

Anti-BP180 Autoantibodies Are Present in Stroke and Recognize Human Cutaneous BP180 and BP180-NC16A
por: Wang, Yanan, et al.
Publicado: (2019)

When Bullous Pemphigoid Is Not Bullous Pemphigoid: The Importance of Going Beyond Direct Immunofluorescence
por: Hopkins, Christina R, et al.
Publicado: (2022)

Retraction: Comparative Analysis of BIOCHIP Mosaic-Based Indirect Immunofluorescence With Direct Immunofluorescence in Diagnosis of Autoimmune Bullous Diseases: A Cross-Sectional Study
Publicado: (2021)

Evaluation of the Role of Oral Mucosal Direct Immunofluorescence and Salivary Desmoglein 1 and 3 Enzyme-Linked Immunosorbent Assay in Patients With Oral Mucosal Pemphigus
por: Asokan, Sushmitha, et al.
Publicado: (2022)

Use of gliptins reduces levels of SDF-1/CXCL12 in bullous pemphigoid and type 2 diabetes, but does not increase autoantibodies against BP180 in diabetic patients
por: Nätynki, Antti, et al.
Publicado: (2022)

Bullous pemphigoid anti-BP180-NC16A autoantibody reactivity in healthy individuals is associated with marked hypovitaminosis D and Th2-like cytokine predominance
por: Tukaj, Stefan, et al.
Publicado: (2022)

The significance of preclinical anti-BP180 autoantibodies
por: Mai, Yosuke, et al.
Publicado: (2022)

Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid
por: Sadik, Christian D., et al.
Publicado: (2019)

Serological diagnosis of autoimmune bullous skin diseases: Prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy
por: van Beek, Nina, et al.
Publicado: (2012)

BP180/Collagen XVII: A Molecular View
por: Tuusa, Jussi, et al.
Publicado: (2021)

Accuracy of molecular diagnostics in pemphigus and bullous pemphigoid: comparison of commercial and modified mosaic indirect immunofluorescence tests as well as enzyme-linked immunosorbent assays
por: Gornowicz-Porowska, Justyna, et al.
Publicado: (2017)

Bullous pemphigoid
por: Miyamoto, Denise, et al.
Publicado: (2019)

Anti-desmoglein Autoantibody in a Patient with Bullous Pemphigoid - A Case Report
por: Rai, Reena, et al.
Publicado: (2022)

Analysis of the autoimmune response to BP180 in Chinese stroke patients()
por: Wang, Jing, et al.
Publicado: (2023)

Clinical Features and Outcomes of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid (DPP4i-Associated BP) in Thai Patients
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2020)

Bullous Pemphigoid and Other Pemphigoid Dermatoses
por: Pratasava, Valeryia, et al.
Publicado: (2021)

Comparative Analysis of BIOCHIP Mosaic-Based Indirect Immunofluorescence with Enzyme-Linked Immunosorbent Assay for Diagnosing Myasthenia Gravis
por: Gambino, Caterina Maria, et al.
Publicado: (2021)

Resolution in bullous pemphigoid
por: Sadik, Christian D., et al.
Publicado: (2019)

Esophageal Bullous Pemphigoid
por: Castelo Branco, Catarina, et al.
Publicado: (2022)

Dyshidrosiform Bullous Pemphigoid
por: Cohen, Philip R.
Publicado: (2021)

Case report: Detection of anti-bullous pemphigoid antigen 180 antibodies in a patient with Behçet’s disease
por: Didona, Dario, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_emtmoer1vrbgbtkedpf5brie0e